In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer (Q42279298)
Jump to navigation
Jump to search
scientific article published on 3 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer |
scientific article published on 3 August 2013 |
Statements
1 reference
In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer (English)
1 reference
Hua Li Wang
1 reference
Hui Xu
1 reference
Wei Hua Lu
1 reference
Lin Zhu
1 reference
Yun Hai Yu
1 reference
Fan Zhen Hong
1 reference
3 August 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference